Condition: HIV · Hepatitis C Virus (HCV) · Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
This study is focused on improving the implementation of Prison Needle Exchange Programs (PNEPs) in Canadian federal prisons, with the goal of increasing the uptake of these programs among people who inject drugs in prison. The study is being conducted in nine federal prisons, including five women's prisons, where a higher proportion of incarcerated individuals report a history of injection drug use. This study aims to improve PNEP adoption and sustainability by identifying barriers and facilitators and implementing evidence-based strategies to enhance program engagement.
This description comes directly from the study's public registry record.
Nadine Kronfli · 514-934-1934 · nadine.kronfli@mcgill.ca
Always discuss trial participation with your own doctor first.
| Edmonton Institution for Women | Edmonton, Alberta, Canada | Not Yet Recruiting |
| Fraser Valley Institution for Women | Abbotsford British Columbia, British Columbia, Canada | Not Yet Recruiting |
| Mission Institution | Mission, British Columbia, Canada | Not Yet Recruiting |
| Dorchester Medium | Dorchester, New Brunswick, Canada | Recruiting |
| Atlantic Institution | Smiths Crossing, New Brunswick, Canada | Recruiting |
| Nova Institution for Women | Truro, Nova Scotia, Canada | Recruiting |
| Joyceville Institution | Kingston, Ontario, Canada | Not Yet Recruiting |
| Grand Valley Institution for Women | Kitchener, Ontario, Canada | Not Yet Recruiting |
| Joliette Institution for Women | Joliette, Quebec, Canada | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07122219